- Half Year 2023 Genfit SA Earnings Call TranscriptSep 20, 2023$3.72 (+4.49%)Earnings
- Genfit SA and Ipsen SA Announce Positive Results from Phase III ELATIVE® Trial of Elafibranor in Patients with Primary Biliary Cholangitis Call TranscriptJun 30, 2023
- Full Year 2022 Genfit SA Earnings Call TranscriptApr 14, 2023$4 (-1.48%)Earnings
- Genfit SA to Acquire Clinical-Stage Biopharmaceutical Company Versantis AG Call TranscriptSep 19, 2022
- Full Year 2022 Genfit SA Earnings Call TranscriptApr 08, 2022$3.95 (+0.77%)Earnings
- Genfit SA Corporate Call TranscriptDec 17, 2021
- Half Year 2021 Genfit SA Earnings Call TranscriptSep 29, 2021$3.77 (-1.05%)Earnings
- Genfit SA Updates On Pipeline TranscriptMay 11, 2021
- Full Year 2020 Genfit SA Earnings Presentation TranscriptApr 01, 2021
- Half Year 2020 Genfit SA Earnings Call (English) TranscriptSep 30, 2020$5.27 (-3.30%)Earnings
- Q4 2019 Genfit SA Earnings Call TranscriptApr 09, 2020$16.19 (-1.88%)Earnings
Half Year 2021 Genfit SA Earnings Call Transcript
Good day, everyone, and welcome to the GENFIT First Half Year 2021 Financial Results and Corporate Update Call. Today's call is being recorded. At this time, I would like to turn the conference over to Stefanie Magner, Chief Compliance Officer, VP, International Legal Affairs. Please go ahead.
Thank you, and good afternoon, everyone. Thanks for joining us for our 2021 half year financial results call. We just issued a press release providing our 2021 half year results. This press release can be accessed on our website at ir.genfit.com. During our call, including during the Q&A session, we'll be making forward-looking statements with respect to GENFIT, including those within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding our new strategy and objectives, size and relative or accessibility of the PBC market, anticipated time lines and dates for commencement of clinical studies as well as clinical data release, in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)